CellReGen

CellReGen is a clinical-stage biotechnology company focused on developing regenerative medicine solutions for cardiovascular and metabolic diseases. Founded by Dr. Amit Patel, a pioneer in cardiac stem cell therapy, the company leverages advanced cell therapy platforms to treat conditions such as heart failure and critical limb ischemia. Their approach typically involves the use of autologous or allogeneic stem cells to promote angiogenesis and tissue repair in ischemic environments. CellReGen aims to provide minimally invasive treatments that restore function to damaged organs and limbs, potentially reducing the need for major surgical interventions or amputations. The company's proprietary delivery methods, including retrograde coronary sinus infusion, are designed to enhance the precision and efficacy of cell delivery to the heart.